United Kingdom Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery



Summary



GlobalData’s new report, “United Kingdom Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery” provides key market data on the United Kingdom Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the United Kingdom Diabetes Care Devicesmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Sanofi, Eli Lilly and Company, LifeScan, Inc., Becton, Dickinson and Company and others.



Reasons to buy


- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United Kingdom Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table Of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In United Kingdom 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2011 12
3.4 Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 13
3.5 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 20
4 Glucose Monitoring In United Kingdom 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2011 23
4.3 Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 24
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 25
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 29
4.5 Glucose Monitoring Overall Volume (2004-2018) 33
4.5.1 Blood Glucose Meters, Volume (2004-2018) 37
4.6 Glucose Monitoring Average Price (2004-2018) 41
4.7 Glucose Monitoring Distribution Share (2010-2011) 42
4.8 Glucose Monitoring, United Kingdom, Company Share (2010-2011) 43
5 Insulin Delivery In United Kingdom 45
5.1 Insulin Delivery, Market Segmentation 45
5.2 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2011 46
5.3 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 47
5.4 Insulin Delivery Overall Revenue, (2004-2018) 48
5.4.1 Insulin Pens, Revenue (2004-2018) 52
5.4.2 Insulin Pumps, Revenue (2004-2018) 56
5.5 Insulin Delivery Overall Volume (2004-2018) 60
5.5.1 Insulin Pens, Volume (2004-2018) 64
5.5.2 Insulin Pumps, Volume (2004-2018) 68
5.6 Insulin Delivery Average Price (2004-2018) 72
5.7 Insulin Delivery Distribution Share (2010-2011) 74
5.8 Insulin Delivery, United Kingdom, Company Share (2010-2011) 75
6 Overview of Key Companies in United Kingdom Diabetes Care Devices Market 77
6.1 F. Hoffmann-La Roche Ltd. 77
6.1.1 Company Overview 77
6.1.2 Share in the United Kingdom Diabetes Care Devices Market 77
6.2 Novo Nordisk A/S 78
6.2.1 Company Overview 78
6.2.2 Share in the United Kingdom Diabetes Care Devices Market 78
6.3 Sanofi 79
6.3.1 Company Overview 79
6.3.2 Share in the United Kingdom Diabetes Care Devices Market 79
6.4 Eli Lilly and Company 80
6.4.1 Company Overview 80
6.4.2 Share in the United Kingdom Diabetes Care Devices Market 80
6.5 LifeScan, Inc. 81
6.5.1 Company Overview 81
6.5.2 Share in the United Kingdom Diabetes Care Devices Market 81
6.6 Becton, Dickinson and Company 82
6.6.1 Company Overview 82
6.6.2 Share in the United Kingdom Diabetes Care Devices Market 82
6.7 Bayer HealthCare AG 83
6.7.1 Company Overview 83
6.8 Abbott Laboratories 83
6.8.1 Company Overview 83
6.9 Medtronic, Inc. 84
6.9.1 Company Overview 84
6.10 Animas Corporation 84
6.10.1 Company Overview 84
6.11 Ypsomed Holding AG 85
6.11.1 Company Overview 85
6.12 Home Diagnostics (UK) Limited 85
6.12.1 Company Overview 85
6.13 ARKRAY, Inc. 85
6.13.1 Company Overview 85
6.14 B. Braun Melsungen AG 86
6.14.1 Company Overview 86
7 Diabetes Care Devices Market Pipeline Products 87
8 Financial Deals Landscape 91
8.1 Partnerships 91
8.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 91
8.1.2 Mendor Enters Into Distribution Agreement With Merck Serono 92
9 Recent Developments 93
9.1 Research And Development 93
9.1.1 Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug Research 93
9.2 Product News 94
9.2.1 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring System Helps To Improve Patient Care 94
10 Appendix 95
10.1 Definitions of Markets Covered in the Report 96
10.1.1 Diabetes Care Devices 96
10.2 Research Methodology 98
10.3 Secondary Research 98
10.4 Primary Research 99
10.5 Models 99
10.6 Forecasts 100
10.7 Expert Panels 100
10.8 GlobalData Consulting 100
10.9 Currency Conversion 100
10.10 Contact Us 101
10.11 Disclaimer 101

1.1 List of Tables

Table 1: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 11
Table 2: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 13
Table 3: Diabetes Care Devices, United Kingdom, Cross-Segment Analysis, 2004-2018 15
Table 4: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17
Table 5: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19
Table 6: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 21
Table 7: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 24
Table 8: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 26
Table 9: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 28
Table 10: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 30
Table 11: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 32
Table 12: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 34
Table 13: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 36
Table 14: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 38
Table 15: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 40
Table 16: Glucose Monitoring, United Kingdom, Average Price ($), Historic, 2004-2011 41
Table 17: Glucose Monitoring, United Kingdom, Average Price ($), Forecast, 2011-2018 41
Table 18: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 42
Table 19: Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 44
Table 20: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 47
Table 21: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 49
Table 22: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 51
Table 23: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 53
Table 24: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 55
Table 25: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 57
Table 26: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 59
Table 27: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 61
Table 28: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 63
Table 29: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 65
Table 30: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 67
Table 31: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 69
Table 32: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 71
Table 33: Insulin Delivery, United Kingdom, Average Price ($), Historic, 2004-2011 72
Table 34: Insulin Delivery, United Kingdom, Average Price ($), Forecast, 2011-2018 73
Table 35: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 74
Table 36: Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 76
Table 37: Diabetes Care Devices Market Pipeline Products 87
Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 91
Table 39: Mendor Enters Into Distribution Agreement With Merck Serono 92

1.2 List of Figures

Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 3: Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2011 12
Figure 4: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 13
Figure 5: Diabetes Care Devices, United Kingdom, Cross-Segment Analysis, 2004-2018 14
Figure 6: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16
Figure 7: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18
Figure 8: Diabetes Care Devices, United Kingdom, Company Share (%), 2011 20
Figure 9: Glucose Monitoring, Market Segmentation 22
Figure 10: Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2011 23
Figure 11: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 24
Figure 12: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 25
Figure 13: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 27
Figure 14: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 29
Figure 15: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 31
Figure 16: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 33
Figure 17: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 35
Figure 18: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 37
Figure 19: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 39
Figure 20: Glucose Monitoring, United Kingdom, Company Share (%), 2011 43
Figure 21: Insulin Delivery, Market Segmentation 45
Figure 22: Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2011 46
Figure 23: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 47
Figure 24: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 48
Figure 25: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 50
Figure 26: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 52
Figure 27: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 54
Figure 28: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 56
Figure 29: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 58
Figure 30: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 60
Figure 31: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 62
Figure 32: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 64
Figure 33: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 66
Figure 34: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 68
Figure 35: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 70
Figure 36: Insulin Delivery, United Kingdom, Company Share (%), 2011 75
Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 77
Figure 38: Novo Nordisk A/S, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 78
Figure 39: Sanofi, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 79
Figure 40: Eli Lilly and Company, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 80
Figure 41: LifeScan, Inc., Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 81
Figure 42: Becton, Dickinson and Company, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 82

Companies mentioned
F. Hoffmann-La Roche Ltd.
Novo Nordisk A/S
Sanofi
Eli Lilly and Company
LifeScan, Inc.
Becton, Dickinson and Company
Bayer HealthCare AG
Abbott Laboratories
Medtronic, Inc.
Animas Corporation
Ypsomed Holding AG
Home Diagnostics (UK) Limited
ARKRAY,

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, ...

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most ...

Analytical Tool - Hematological Cancers

Analytical Tool - Hematological Cancers

  • $ 8 925
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.